Metraipolis › archive › dc_f8d355f4f7bb

Aryl Hydrocarbon Receptor (AhR) and Vascular Endothelial Growth Factor (VEGF) Crosstalk in Doxorubicin Nephrotoxicity: Mechanisms and Therapeutic Perspectives — Europe PMC PMID:41614946

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41614946
DOI
10.3390/cimb48010116
License (as archived)
solo-consultazione
Archived
2026-11-06T14:00:06.077Z
SHA-256 of the archived text
3a82d839463891dfcb8304c319b477be8fd48a6ec47ee95b0d93cf2e987d1c86
Stable URL of this page
https://metraipolis.com/documento/dc_f8d355f4f7bb

How to cite

Aryl Hydrocarbon Receptor (AhR) and Vascular Endothelial Growth Factor (VEGF) Crosstalk in Doxorubicin Nephrotoxicity: Mechanisms and Therapeutic Perspectives — Europe PMC PMID:41614946 — Europe PMC (en), https://europepmc.org/article/MED/41614946 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f8d355f4f7bb (Metraipolis archive dc_f8d355f4f7bb, sha256 3a82d839463891dfcb8304c319b477be8fd48a6ec47ee95b0d93cf2e987d1c86)
BibTeX
@misc{dcf8d355f4f7bb,
  title = {Aryl Hydrocarbon Receptor (AhR) and Vascular Endothelial Growth Factor (VEGF) Crosstalk in Doxorubicin Nephrotoxicity: Mechanisms and Therapeutic Perspectives — Europe PMC PMID:41614946},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41614946},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f8d355f4f7bb; sha256 3a82d839463891dfcb8304c319b477be8fd48a6ec47ee95b0d93cf2e987d1c86},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41614946. Agents can read the archived copy with the MCP tool read_document.